Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Neuro-Oncology
Published in: Journal of Neuro-Oncology 2/2024

22-03-2024 | Dexamethasone | Correspondence

Letter to the editor: Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis

Authors: Peter G. Zaki, Sanjeev Herr, Matthew J. Shepard

Published in: Journal of Neuro-Oncology | Issue 2/2024

Login to get access

Excerpt

We have thoroughly read the study by Arora et al. regarding the effects of dexamethasone on patients with newly diagnosed high-grade gliomas (HGG) and the impact of its use on both overall survival and progression-free survival [1]. Their meta-analysis involved a diverse cohort of 1,257 patients across seven studies spanning from January 1, 2007, to May 31, 2023. Their comprehensive analysis demonstrated that the use of dexamethasone before or during surgery is associated with poorer overall survival and progression-free survival rates. …
Literature
1.
2.
3.
Metadata
Title
Letter to the editor: Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis
Authors
Peter G. Zaki
Sanjeev Herr
Matthew J. Shepard
Publication date
22-03-2024
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 2/2024
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-024-04602-9

Other articles of this Issue 2/2024

Journal of Neuro-Oncology 2/2024 Go to the issue

Research

Diverse learners: learning disabilities and quality of life following mind–body and health education interventions for adults with neurofibromatosis

Correspondence

Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence

Research

Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response

Case Study

Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma

Correction

Correction to: Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy

Research

Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years’ experience of a single center